MiNK Therapeutics(INKT) - 2025 Q1 - Earnings Call Transcript

Mink Therapeutics (INKT) Q1 2025 Earnings Call May 15, 2025 08:30 AM ET Company Participants Zack Armen - Head of IR & Corporate DevelopmentJennifer Buell - President and CEOChristine Klaskin - CFOThiago Favano - Senior Director, Portfolio Operations Conference Call Participants Emily Bodnar - Biotech Equity Research AnalystMatthew Phipps - Equity Research Analyst Operator Thank you for standing by. My name is Roselle, and I will be your conference operator today. At this time, I would like to welcome every ...